It has been reported that TNFR2 is abnormally expressed on various tumor cells such as those of breast cancer, ovarian cancer, skin cancer, renal cell carcinoma, colon cancer, and multiple myeloma (77, 86–91). Here, TNFRSF1B is linked to breast carcinoma.